Nath Karl A, d'Uscio Livius V, Juncos Julio P, Croatt Anthony J, Manriquez Melissa C, Pittock Siobhan T, Katusic Zvonimir S
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H333-42. doi: 10.1152/ajpheart.00870.2006. Epub 2007 Mar 9.
Heme oxygenase-1 (HO-1) is induced in the vasculature in the DOCA-salt model of hypertension in rats. Whereas the HO system and its products may exert vasodilator effects, recent studies have suggested that the HO system may predispose to hypertension. The present study examined the effects of selected components of the HO system, specifically, the HO-1 isozyme and the product bilirubin in the DOCA-salt model of systemic hypertension; the experimental approach employed mutant rodent models, namely, the HO-1(-/-) mouse and the hyperbilirubinemic Gunn rat. DOCA-salt induced HO-1 protein in the aorta in HO-1(+/+) mice and provoked a significant rise in systolic arterial pressure in HO-1(-/-) mice but not in HO-1(+/+) mice; this effect could not be ascribed to impaired urinary sodium excretion or impaired glomerular filtration rate in the DOCA-salt-treated HO-1(-/-) mice. The administration of DOCA salt to uninephrectomized rats significantly increased systolic arterial pressure in wild-type rats, an effect that was attenuated in the mutant Gunn rat; this reduction in systemic hypertension in the DOCA-salt-treated Gunn rat was not due to a greater induction of HO-1 in the vasculature or to a more avid urinary sodium excretion. DOCA-salt impaired endothelium-dependent and endothelium-independent vasorelaxation in wild-type rats but not in Gunn rats; prior exposure to bilirubin repaired the defect in endothelium-dependent vasorelaxation in aortic rings in DOCA-salt-treated rats. DOCA salt stimulated vascular production of superoxide anion in wild-type but not in Gunn rats. We suggest that HO-1 and the product bilirubin may exert a countervailing effect in the DOCA-salt model of systemic hypertension.
血红素加氧酶-1(HO-1)在大鼠去氧皮质酮盐高血压模型的血管系统中被诱导产生。虽然HO系统及其产物可能发挥血管舒张作用,但最近的研究表明,HO系统可能易导致高血压。本研究在系统性高血压的去氧皮质酮盐模型中,研究了HO系统特定成分的作用,具体而言,是HO-1同工酶和产物胆红素的作用;实验方法采用了突变啮齿动物模型,即HO-1(-/-)小鼠和高胆红素血症的冈恩大鼠。去氧皮质酮盐在HO-1(+/+)小鼠的主动脉中诱导HO-1蛋白产生,并在HO-1(-/-)小鼠中引起收缩动脉压显著升高,但在HO-1(+/+)小鼠中未出现这种情况;这种效应不能归因于去氧皮质酮盐处理的HO-1(-/-)小鼠尿钠排泄受损或肾小球滤过率受损。给单侧肾切除的大鼠注射去氧皮质酮盐可显著增加野生型大鼠的收缩动脉压,而在突变的冈恩大鼠中这种效应减弱;去氧皮质酮盐处理的冈恩大鼠系统性高血压的降低并非由于血管中HO-1的诱导增加或尿钠排泄更活跃。去氧皮质酮盐损害野生型大鼠的内皮依赖性和非内皮依赖性血管舒张,但对冈恩大鼠无此影响;预先暴露于胆红素可修复去氧皮质酮盐处理大鼠主动脉环中内皮依赖性血管舒张的缺陷。去氧皮质酮盐刺激野生型大鼠而非冈恩大鼠的血管超氧阴离子生成。我们认为,HO-1和产物胆红素在系统性高血压的去氧皮质酮盐模型中可能发挥抵消作用。